by adminAdrianRamirez | Dec 4, 2018 | HempMeds Mexico, Press Releases
SAN DIEGO, Dec. 4, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that subsidiary HempMeds® Mexico will be a Platinum Sponsor at the Cannapeutas Clinical Perspective Cannabinoid...
by adminAdrianRamirez | Nov 26, 2018 | HempMeds Mexico, Press Releases
SAN DIEGO, Nov. 26, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® Mexico has received five new permits from the Mexican Federal Commission for Protection...
by adminAdrianRamirez | Nov 13, 2018 | HempMeds Brasil, HempMeds Mexico, Press Releases
SAN DIEGO, Nov. 13, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that subsidiary HempMeds® Brasil will be a premier sponsor at the CannX Brazil Conference in São Paulo on Nov....
by adminAdrianRamirez | Nov 2, 2018 | HempMeds, HempMeds Mexico, Media Coverage
Interviews with our CEO, cannabis legalization on our northern and southern borders, and the benefits of CBD are among Medical Marijuana, Inc.’s top stories this week. Once again, Medical Marijuana, Inc. and our family of companies have made headlines around the...
by adminAdrianRamirez | Oct 30, 2018 | HempMeds Mexico, Press Releases
SAN DIEGO, Oct. 30, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that subsidiary HempMeds® Mexico President Raul Elizalde will speak at the 2018 Hemp Industries Association 25th...
by adminAdrianRamirez | Aug 3, 2018 | HempMeds Mexico, Media Coverage
Legalization of medical cannabis in Mexico and CBD pet treats from Phyto Animal Health lead headlines from our portfolio of companies. Medical Marijuana, Inc., the first publicly traded cannabis company in the U.S., was featured in a number of national and...